- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
Brandon Bernard, MD, MPH | Authors
POINT-Prostate Cancer Genomic Analysis: Routine or Research Only?
December 17, 2018
In this side of the Point/Counterpoint, Drs. Bernard and Flaig state that genomic testing should be routine in the management of prostate cancer patients.
Complications of Androgen Deprivation Therapy in Men With Prostate Cancer
September 18, 2018
This article summarizes the key side effects associated with ADT for the treatment of prostate cancer and discusses strategies to optimize management.
Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification
July 15, 2018
A 62-year-old man with prostate adenocarcinoma elected to proceed with radical prostatectomy as definitive management. After his pathology report showed stage IIIB disease, he elected for observation. What happened next?